Genome Editing to Eliminate Retrotransposons for Aging Intervention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The increasing average human lifespan without a corresponding decrease in biological aging rate leads to the prevalence of age-associated diseases, which are often managed with symptomatic treatments, resulting in significant economic and social burdens, and current methods are inadequate for effectively addressing the underlying causes of aging.
Innovation Solution
Genetic engineering to modify nucleotide sequences in the human genome, generating universally histocompatible cells for transplantation to slow aging and treat age-associated disorders, while avoiding destruction by natural killer cells, and eliminating active retrotransposons to enhance genome integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If symptomatic treatments are used for age-associated diseases, then patient comfort is improved, but the underlying aging process is not addressed and disease burden increases
Solution Approach 1:
The patent extracts and eliminates harmful elements (retrotransposons) from the genome to address the root cause of aging rather than treating symptoms. This involves using genome editing technologies to remove specific genetic sequences that contribute to cellular senescence and age-related diseases, thereby transforming the approach from symptomatic management to causal intervention.
Solution Approach 2:
The patent applies preliminary action by modifying the genome before diseases manifest to prevent aging-related conditions. Through pre-emptive genome editing, harmful retrotransposons are eliminated in advance, and protective genetic modifications are made to slow biological aging rates, thereby preventing rather than treating age-associated diseases.
2Duration of action of moving object
If genetic modifications are made to slow aging, then lifespan potential is improved, but genome stability and safety concerns arise
Solution Approach 1:
The patent converts harmful retrotransposons into beneficial targets for elimination. By identifying and removing these previously harmful elements, the genome is purified of age-accelerating factors. The approach transforms the problem of genetic modification safety into an opportunity to eliminate known harmful sequences while preserving beneficial genetic functions.
Solution Approach 2:
The patent changes genetic parameters by modifying specific nucleotide sequences and removing retrotransposon elements from the genome. This involves precise alterations to DNA structure, such as deleting specific sequences and repairing damaged regions, thereby changing the genetic parameters that control aging rates while maintaining overall genome stability.
3Productivity
If population size increases to address aging problems, then labor force is improved, but environmental sustainability deteriorates
Solution Approach 1:
The patent changes the biological parameter of human lifespan through genome editing, extending the healthy lifespan without increasing population size. By modifying genes that control aging rates and eliminating harmful retrotransposons, the approach extends the productive years of individuals, thereby maintaining labor force productivity while avoiding the environmental pressures of population growth.
Solution Approach 2:
The patent introduces dynamic control of aging rates through editable genetic parameters. Rather than accepting fixed biological aging, the approach enables adjustable lifespan parameters through genome modification, allowing optimization of individual longevity without requiring population expansion, thus decoupling productivity from environmental impact.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach potentially increases human lifespan by reducing senescence in tissues and organs, delaying age-associated diseases, and providing healthier aging, with engineered cells showing improved maintenance of genome integrity and reduced risk of neoplastic transformation.
Implementation Method 1
Genetic engineering to modify nucleotide sequences in the human genome
Implementation Method 2
engineered cells showing improved maintenance of genome integrity
Implementation Method 3
avoiding destruction by natural killer cells
Data Source
AI summary
The diseases and disabilities associated with aging are at roots of growing unsolved problems in human societies worldwide and the basic problem is inherent in human genome and biology. Increases of average human lifespan without a decrease of rate of aging have been causing increases in frequencies of the diseases of aging whose symptomatic treatments have limited benefits. Here it is shown with exemplification that identifications and targeting of the decisive upstream mechanisms of biological aging and of age associated diseases can provide effective solutions to the problem.